Review of: "Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review"
February 1, 2026 Carlton J. Spotswood
A review of psilocybin as a treatment for alcohol use disorder (AUD) examines the history, mechanisms, and clinical evidence for psychedelic-assisted therapy. The authors argue that psilocybin, when combined with psychotherapy, may help reduce alcohol consumption and support abstinence by disrupting maladaptive neural patterns and enhancing psychological insight. The text notes that psilocybin at 25 mg/70 kg produces robust psychedelic effects, contrary to a claim that it does not. Adverse effects are discussed, but the review does not present original data. The authors suggest psilocybin shows promise for AUD but emphasize the need for further controlled trials.